The timing of when human biological clocks first tick has long puzzled researchers, with implications for understanding sleep disorders, metabolic health, and optimal birth outcomes. This breakthrough reveals that circadian rhythms don't simply switch on at birth but gradually emerge and align with maternal patterns during pregnancy itself.
Using engineered mouse models with luminescent PERIOD2 proteins, scientists tracked circadian development from embryonic day 8.5 through 17.5. The fetoplacental unit showed increasing PER2 expression throughout pregnancy, with daily peak timing initially variable but stabilizing to early nighttime patterns by day 15.5. Critically, pregnancies lacking detectable daily PER2 variation were significantly more likely to fail, suggesting synchronized circadian function may be essential for successful gestation.
The maternal hormone corticosterone emerged as a key synchronizing signal. Five-day corticosterone injections could shift fetal circadian timing in a phase-dependent manner, while blocking glucocorticoid receptors disrupted maternal-fetal synchrony in tissue cultures.
This finding fundamentally reframes our understanding of circadian development. Rather than passive passengers, developing fetuses actively establish and coordinate their biological clocks with maternal rhythms well before birth. The glucocorticoid pathway provides a previously unknown mechanism linking maternal stress hormones to fetal clock entrainment. For expectant mothers, this suggests that maintaining consistent sleep-wake cycles and managing stress may influence fetal circadian development. The research also opens new avenues for understanding pregnancy complications linked to circadian disruption, from shift work to jet lag during gestation.